Transition zone prostate specific antigen density: Lack of use in prediction of prostatic carcinoma

Journal of Urology

Volumn 160, Issue 1, 1998, Pages 77-82

  Lin, Daniel W ^a   Gold, Mitchell H ^a   Ransom, Sean ^a   Ellis, William J ^a   Brawer, Michael K ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Northwest Prostate Institute   (United States)

Author keywords

Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RELIABILITY;

EID: 0032324328     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63036-2     Document Type: Article

References (26)

1. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907, 1991.
2. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A. and Andriole, G. L.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
3. Brawer, M. K., Chetner, M. P., Beatie, J., Buchner, D. M., Vessella, R. L. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147: 841, 1992.
4. Brawer, M. K., Beattie, J., Wener, M. H., Vessella, R. L., Preston, S. D. and Lange, P. H.: Screening for prostatic carcinoma with PSA: results of the second year. J. Urol., 150: 106, 1993.
5. Carter, H. B., Pearson, J. D., Waclawiw, Z., Metter, E. J., Chan, D. W., Guess, H. A. and Walsh, P. C.: Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity. Urology, 45: 591, 1995.
6. Smith, D. S. and Catalona, W. J.: Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J. Urol., 152: 1163, 1994.
7. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
8. Dalkin, B. L., Ahmann, F. R. and Kopp, J. B.: Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J. Urol., 150: 1837, 1993.
9. Lilja, H.: Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha-1-antichymotrypsin. Urol. Clin. N. Amer., 20: 681, 1993.
10. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., 147: 817, 1992.
11. Benson, M. C., Whang, I. S., Pantuck, A., Ring, K., Kaplan, S. A., Olsson, C. A. and Cooner, W. H.: Prostate-specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol., 147: 815, 1992.
12. Rommel, F. M., Augusta, V. E., Breslin, J. A., Huffnagle, H. W., Pohl, C. E., Sieber, P. R. and Stahl, C. A.: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J. Urol., 151: 88, 1994.
13. Seaman, E., Whang, M., Olsson, C. A., Katz, A., Cooner, W. H. and Benson, M. C.: PSA density (PSAD): Role in patient evaluation and management. Urol. Clin. N. Amer., 20: 653, 1993.
14. Ohori, M., Dunn, J. K. and Scardino, P. T.: Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer. Urology, 46: 666, 1995.
15. Cookson, M. S., Floyd, M. K., Ball, T. P., Jr., Miller, E. K. and Sarosdy, M. F.: The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J. Urol., 154: 1070, 1995.
16. Catalona, W. J., Richie, J. P., deKernion, J. B., Ahmann, F. R., Ratliff, T. L., Dalkin, B. L., Kavoussi, L. R., MacFarlane, M. T. and Southwick, P. C.: Comparison of prostate specific antigen concentrations versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J. Urol., 152: 2031, 1994.
17. Brawer, M. K., Aramburu, E. A. G., Chen, G. L., Preston, S. D. and Ellis, W. J.: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J. Urol., 150: 369, 1993.
18. Brawer, M. K.: How to use PSA in the early detection or screening for prostatic carcinoma. CA, 45: 148, 1995.
19. Hammerer, P. G., McNeal, J. E. and Stamey, T. E.: Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J. Urol., 153: 111, 1995.
20. Lepor, H., Wang, B. and Shapiro, E.: The relationship between prostatic intraepithelial volume and serum PSA levels. J. Urol., part 2, 151: 294A, abstract 265, 1994.
21. Kalish, J., Cooner, W. H. and Graham, S. D., Jr.: Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology, 43: 601, 1994.
22. Maeda, H., Ishitoya, S., Maekawa, S., Aoki, Y., Okubo, K., Okada, T., Suzuki, Y. and Arai, Y.: Prostate specific antigen density of the transition zone in the detection of prostate cancer. J. Urol., 158: 2193, 1997.
23. Zlotta, A. R., Djavan, B., Marberger, M. and Schulman, C. C.: Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J. Urol., 157: 1315, 1997.
24. Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol., 142: 71, 1989.
25. Mettlin, C., Littrup, P. J., Kane, R. J., Murphy, G. P., Lee, F., Chesley, A., Badalament, R. and Mostofi, F. K.: Relative sensitivity and specificity of serum PSA level compared with age-referenced PSA, PSA density and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project. Cancer, 74: 1615, 1994.
26. Presti, J. C., Jr., Hovey, R., Carroll, P. R. and Shinohara, K.: Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. J. Urol., 156: 1685, 1996.